IP Library › Assignment 060616/0487
Patent Assignment
Reel/Frame 060616/0487

Security Interest

Recorded: 2022-07-08 Pages: 34
Assignors
ENSYSCE BIOSCIENCES, INC.
Executed: 2022-06-30
EBI OPCO, INC.
Executed: 2022-06-30
EBI OPERATING, INC.
Executed: 2022-06-30
COVISTAT, INC.
Executed: 2022-06-30
Assignee
3I, LP
140 BROADWAY, 38TH FLOOR, NEW YORK, NEW YORK, 10005
Covered Properties (50)
Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof
Application: 16/656,409 →
Publication: US 2020/0253900
Modified Release Compositions of Nafamostat and Methods of Using Same
Application: 17/689,255 →
Publication: US 2022/0287975
Compositions Comprising Enzyme-Cleavable Prodrugs and Controlled Release Nafamostat and Methods of Use Thereof
Application: 17/689,271 →
Publication: US 2022/0287992
Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof
Application: 17/436,041 →
Publication: US 2022/0175699
Enzyme-Cleavable Methadone Prodrugs and Methods of Use Thereof
Application: 63/250,041 →
Single-Walled Carbon Nanotube/Sirna Complexes and Methods Related Thereto
Patent: 8,772,258 →
Application: 13/175,314 →
Publication: US 2012/0003278
Prodrugs of Active Agents
Patent: 8,163,701 →
Application: 11/508,042 →
Publication: US 2007/0123468
Controlled Release of Phenolic Opioids
Patent: 8,217,005 →
Application: 12/302,764 →
Publication: US 2010/0035826
Controlled Release of Phenolic Opioids
Patent: 8,921,418 →
Application: 13/486,613 →
Publication: US 2012/0270894
Pro-Drugs for Controlled Release of Biologically Active Compounds
Patent: 9,023,860 →
Application: 12/324,383 →
Publication: US 2009/0137618
Pharmaceutical Compositions with Attenuated Release of Phenolic Opioids
Patent: 8,802,681 →
Application: 13/121,335 →
Publication: US 2011/0281886
Pharmaceutical Compositions with Attenuated Release of Phenolic Opioids
Patent: 9,534,014 →
Application: 14/320,351 →
Publication: US 2015/0031635
Compositions Comprising Enzyme-Cleavable Ketone-Modified Opioid Prodrugs and Optional Inhibitors Thereof
Patent: 9,493,477 →
Application: 13/393,470 →
Publication: US 2012/0230916
Compositions Comprising Enzyme-Cleavable Ketone-Modified Opioid Prodrugs and Optional Inhibitors Thereof
Application: 15/285,818 →
Publication: US 2017/0119754
Compositions Comprising Enzyme-Cleavable Oxycodone Prodrug
Patent: 8,569,228 →
Application: 13/346,062 →
Publication: US 2012/0178772
Compositions Comprising Enzyme-Cleavable Oxycodone Prodrug
Patent: 8,962,547 →
Application: 14/035,871 →
Publication: US 2014/0162935
Compositions Comprising Enzyme-Cleavable Oxycodone Prodrug
Patent: 9,499,581 →
Application: 14/593,855 →
Publication: US 2015/0197544
Compositions Comprising Enzyme-Cleavable Oxycodone Prodrug
Patent: 8,497,237 →
Application: 13/346,281 →
Publication: US 2012/0178773
Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof
Application: 15/042,906 →
Publication: US 2016/0235694
Compositions Comprising Enzyme-Cleavable Phenol-Modified Tapentadol Prodrug
Patent: 9,238,020 →
Application: 13/634,530 →
Publication: US 2013/0090379
Compositions Comprising Enzyme-Cleavable Opioid Prodrugs and Inhibitors Thereof
Patent: 9,040,032 →
Application: 13/686,725 →
Publication: US 2013/0210701
Compositions Comprising Enzyme-Cleavable Opioid Prodrugs and Inhibitors Thereof
Patent: 9,585,963 →
Application: 14/692,526 →
Publication: US 2015/0297736
Opioid Prodrugs with Heterocyclic Linkers
Patent: 8,685,916 →
Application: 13/415,790 →
Publication: US 2012/0295834
Opioid Prodrugs with Heterocyclic Linkers
Patent: 9,095,627 →
Application: 14/166,719 →
Publication: US 2014/0206597
Active Agent Prodrugs with Heterocyclic Linkers
Patent: 9,139,612 →
Application: 14/000,594 →
Publication: US 2014/0121152
Carbon Nanotubes Complexed with Multiple Bioactive Agents and Methods Related Thereto
Single-Walled Carbon Nanotube/Sirna Complexes and Methods Related Thereto
Methods for Treating Viral Infections with Nafamostat
Anesthetic Compounds
Anesthetic Compounds
Prodrugs of Active Agents
Prodrugs of Opioids
Pharmaceutical Compositions with Attenuated Release of Phenolic Opioids
Compositions Comprising Enzyme-Cleavable Phenol-Modified Opioid Prodrugs and Inhibitors Thereof
Compositions Comprising Enzyme-Cleavable Hydromorphone Prodrug
Pro-Drugs of Peripheral Phenolic Opioid Antagonists
Peripheral Phenolic Opioid Antagonist
Compositions Comprising Enzyme-Cleavable Ketone-Modified Opioid Prodrugs and Optional Inhibitors Thereof
Compositions Comprising Enzyme-Cleavable Oxycodone Prodrug
Compositions Comprising Enzyme-Cleavable Oxycodone Prodrug
Compositions Comprising Trypsin-Cleavable Amphetamine Prodrugs and Inhibitors Thereof
Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof
Compositions Comprising Enzyme-Cleavable Phenol-Modified Tapentadol Prodrug
Compositions Comprising Enzyme-Cleavable Opioid Prodrugs and Inhibitors Thereof
Compositions Comprising Enzyme-Cleavable Prodrugs of Active Agents and Inhibitors Thereof
Peripheral Opioid Agonists and Peripheral Opioid Antagonists
Opioid Prodrugs with Heterocyclic Linkers
Modified Release Compositions of Nafamostat and Methods of Using Same
Compositions Comprising Enzyme-Cleavable Prodrugs and Controlled Release Nafamostat and Methods of Use Thereof
Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 16, 2007
From: JENKINS, THOMAS E.
To: PHARMACOFORE, INC.
Reel/Frame 018897/0471 →
Assignment of Assignor's Interest Feb 5, 2009
From: JENKINS, THOMAS E.
To: PHARMACOFORE, INC.
Reel/Frame 022213/0548 →
Assignment of Assignor's Interest Jul 24, 2009
From: JENKINS, THOMAS E.; KOLESNIKOV, ALEKSANDR
To: PHARMACOFORE, INC.
Reel/Frame 023004/0505 →
Assignment of Assignor's Interest Apr 20, 2011
From: JENKINS, THOMAS E.; SEROOGY, JULIE D.; WRAY, JONATHAN W.
To: PHARMACOFORE, INC.
Reel/Frame 026156/0210 →
Assignment of Assignor's Interest Aug 1, 2011
From: KIRKPATRICK, D. LYNN; WEISS, MICHELLE K.
To: ENSYSCE BIOSCIENCES, INC.
Reel/Frame 026681/0252 →
Change of Name Mar 2, 2012
From: PHARMACOFORE, INC.
To: SIGNATURE THERAPEUTICS, INC.
Reel/Frame 027800/0461 →
Assignment of Assignor's Interest Mar 2, 2012
From: JENKINS, THOMAS E.; HUSFELD, CRAIG O.; SEROOGY, JULIE D.; WRAY, JONATHAN W.
To: PHARMACOFORE, INC.
Reel/Frame 027799/0899 →
Assignment of Assignor's Interest Mar 15, 2012
From: JENKINS, THOMAS E.; HUSFELD, CRAIG O.
To: SIGNATURE THERAPEUTICS, INC.
Reel/Frame 027871/0916 →
Change of Name Mar 20, 2012
From: PHARMACOFORE, INC.
To: SIGNATURE THERAPEUTICS, INC.
Reel/Frame 027892/0697 →
Change of Name May 9, 2012
From: PHARMACOFORE, INC.
To: SIGNATURE THERAPEUTICS, INC.
Reel/Frame 028185/0192 →
Assignment of Assignor's Interest May 10, 2012
From: JENKINS, THOMAS E.; HUSFELD, CRAIG O.
To: SIGNATURE THERAPEUTICS, INC.
Reel/Frame 028191/0172 →
Change of Name Sep 7, 2012
From: PHARMACOFORE, INC.
To: SIGNATURE THERAPEUTICS, INC.
Reel/Frame 028923/0329 →
Assignment of Assignor's Interest Sep 7, 2012
From: JENKINS, THOMAS E.; KOLESNIKOV, ALEKSANDR
To: PHARMACOFORE, INC.
Reel/Frame 028920/0757 →
Assignment of Assignor's Interest Jun 11, 2014
From: JENKINS, THOMAS E.; HUSFELD, CRAIG O.
To: SIGNATURE THERAPEUTICS, INC.
Reel/Frame 033073/0457 →
Change of Name Oct 15, 2014
From: PHARMACOFORE, INC.
To: SIGNATURE THERAPEUTICS, INC.
Reel/Frame 034009/0199 →
Assignment of Assignor's Interest Oct 15, 2014
From: JENKINS, THOMAS E.; SEROOGY, JULIE D.; WRAY, JONATHAN W.
To: PHARMACOFORE, INC.
Reel/Frame 033957/0558 →
Assignment of Assignor's Interest Mar 30, 2015
From: JENKINS, THOMAS E.; HUSFELD, CRAIG O.
To: SIGNATURE THERAPEUTICS, INC.
Reel/Frame 035291/0665 →
Assignment of Assignor's Interest Jan 27, 2017
From: JENKINS, THOMAS E.; HUSFELD, CRAIG O.; SEROOGY, JULIE D.; WRAY, JONATHAN W.
To: PHARMACOFORE, INC.
Reel/Frame 041112/0182 →
Change of Name Jan 27, 2017
From: PHARMACOFORE, INC.
To: SIGNATURE THERAPEUTICS, INC.
Reel/Frame 041541/0166 →
Release of Security Interest Sep 24, 2018
From: MMV FINANCE INC.
To: NETBASE SOLUTIONS, INC.
Reel/Frame 047140/0588 →
Change of Name Jul 29, 2021
From: PHARMACOFORE, INC.
To: SIGNATURE THERAPEUTICS, INC.
Reel/Frame 057031/0532 →
Assignment of Assignor's Interest Jul 29, 2021
From: JENKINS, THOMAS E.; HUSFELD, CRAIG O.; SEROOGY, JULIE D.; WRA Y, JONATHAN W.
To: PHARMACOFORE, INC.
Reel/Frame 057025/0556 →
Security Interest Oct 4, 2021
From: ENSYSCE BIOSCIENCES, INC.
To: 3I, LP
Reel/Frame 057785/0054 →
Assignment of Assignor's Interest Feb 2, 2022
From: KIRKPATRICK, LYNN
To: ENSYSCE BIOSCIENCES INC.
Reel/Frame 058866/0614 →
Assignment of Assignor's Interest Sep 15, 2022
From: KIRKPATRICK, LYNN
To: ENSYSCE BIOSCIENCES INC.
Reel/Frame 061449/0392 →